50shadesofsun.com
European Medicines Agency recommends licence for cladribine (Mavenclad)
The European Medicines Agency has approved cladribine (brand name Mavenclad) for use with multiple sclerosis. The agency has recommended that a licence should be granted, by the European Commission…